Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.

Saylor PJ, Keating NL, Freedland SJ, Smith MR

Should there be a standard therapy for mantle cell lymphoma?

Smith MR

Salvage of pacemakers and automatic implantable cardioverter-defibrillators using dermis grafts.

Rudolph R, Smith MR, Curtis GP

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis.

Morgans AK, Smith MR

Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.

Hatoum HT, Lin SJ, Guo A, Lipton A, Smith MR

Increased cartilage oligomeric matrix protein concentrations in equine digital flexor tendon sheath synovial fluid predicts intrathecal tendon damage.

Smith MR, Wright IM, Minshall GJ, Dudhia J, Verheyen K, Heinegård D, Smith RK

Foreword: skeletal complications of cancer.

Smith MR, Martin TJ

Treatment and prevention of bone complications from prostate cancer.

Lee RJ, Saylor PJ, Smith MR

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.

Younes A, Vose JM, Zelenetz AD, Smith MR, Burris HA, Ansell SM, Klein J, Halpern W, Miceli R, Kumm E, Fox NL, Czuczman MS

Sex with bisexual men among black female students at historically black colleges and universities.

Voetsch AC, Thomas PE, Johnson AS, Millett GA, Mundey L, Goode C, Nobles J, Sly K, Smith MR, Shiloh M, Song B, Green K, Dean HD, Heffelfinger JD